Literature DB >> 10319913

GLUT-4, tumor necrosis factor, essential fatty acids and daf-genes and their role in insulin resistance and non-insulin dependent diabetes mellitus.

U N Das1.   

Abstract

It is now believed that the GLUT-4 receptor, tumor necrosis factor-alpha (TNF-alpha), essential fatty acids (EFAs) and their metabolites and daf-genes have an important role in the development of obesity and non-insulin dependent diabetes mellitus (NIDDM). The protein encoded by daf-2 is 35% identical to the human insulin receptor, daf-7 codes a transforming growth factor-beta (TGF-beta) type signal and daf-16 can enhance superoxide dismutase (SOD) expression. EFAs and their metabolites can alter the cell membrane fluidity and enhance the expression of GLUT-4 and insulin receptors. EFAs can suppress TNF-alpha production and secretion, a mechanism that may have relevance to the role of these fatty acids in the pathogenesis of insulin resistance, obesity and NIDDM. Melatonin has anti-oxidant actions similar to daf-16, TGF-beta and SOD. Based on this evidence, it is proposed that GLUT-4, TNF-alpha, EFAs, daf-genes, melatonin and leptin interact with each other in ways which may have relevance to the development or abrogation of insulin resistance, obesity, NIDDM, complications due to NIDDM, longevity and ageing.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10319913     DOI: 10.1054/plef.1998.0003

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  9 in total

Review 1.  Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction.

Authors:  U N Das
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

2.  Dietary saury oil reduces hyperglycemia and hyperlipidemia in diabetic KKAy mice and in diet-induced obese C57BL/6J mice by altering gene expression.

Authors:  Zhi-Hong Yang; Hiroko Miyahara; Shuhei Takemura; Akimasa Hatanaka
Journal:  Lipids       Date:  2011-04-05       Impact factor: 1.880

3.  Combined effects of EFA deficiency and tumor necrosis factor-alpha on circulating lipoproteins in rats.

Authors:  Emile Levy; Edgard Delvin; Noel Peretti; Guylaine Bouchard; Ernest Seidman
Journal:  Lipids       Date:  2003-06       Impact factor: 1.880

4.  Endocrine and metabolic changes in human aging.

Authors:  W A Banks; J E Morley
Journal:  J Am Aging Assoc       Date:  2000-04

5.  Molecular epidemiologic evidence for diabetogenic effects of dioxin exposure in U.S. Air force veterans of the Vietnam war.

Authors:  Phillip Thomas Fujiyoshi; Joel Edmund Michalek; Fumio Matsumura
Journal:  Environ Health Perspect       Date:  2006-11       Impact factor: 9.031

6.  Long chain polyunsaturated fatty acids (LCPUFAs) and nordihydroguaiaretic acid (NDGA) modulate metabolic and inflammatory markers in a spontaneous type 2 diabetes mellitus model (Stillman Salgado rats).

Authors:  Alejandro Dain; Gaston Repossi; Gustavo T Diaz-Gerevini; Jairam Vanamala; Undurti N Das; Aldo R Eynard
Journal:  Lipids Health Dis       Date:  2016-11-25       Impact factor: 3.876

7.  Response to: Bioactive Lipids and Coronavirus (COVID-19)-further Discussion.

Authors:  Undurti N Das
Journal:  Arch Med Res       Date:  2020-04-15       Impact factor: 2.235

Review 8.  Action of Phytochemicals on Insulin Signaling Pathways Accelerating Glucose Transporter (GLUT4) Protein Translocation.

Authors:  Abu Sadat Md Sayem; Aditya Arya; Hamed Karimian; Narendiran Krishnasamy; Ameya Ashok Hasamnis; Chowdhury Faiz Hossain
Journal:  Molecules       Date:  2018-01-28       Impact factor: 4.411

9.  Lipoteichoic acid from Bifidobacterium animalis subsp. lactis BPL1: a novel postbiotic that reduces fat deposition via IGF-1 pathway.

Authors:  Ferran Balaguer; María Enrique; Silvia Llopis; Marta Barrena; Verónica Navarro; Beatriz Álvarez; Empar Chenoll; Daniel Ramón; Marta Tortajada; Patricia Martorell
Journal:  Microb Biotechnol       Date:  2021-02-23       Impact factor: 5.813

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.